Select Sidearea

Populate the sidearea with useful widgets. It’s simple to add images, categories, latest post, social media icon links, tag clouds, and more.

hello@youremail.com
+1234567890

Author: James Kirwin

Med Tech Gurus Developing The Next Big Thing Ira Spector Co-Founder & CEO of SFA Therapeutics delivers a master class in innovation and new product development. Ira walks us through the best practices of a licensing deal with a university and tell us “don’t be afraid to walk away”. Ira doesn’t stop there, he provides insights into designing elegant experiments and why that is so important in product development. He also...

Read More

PODCASTTreat Disease, Not the SymptomsIn this podcast, Dr. Ira Spector discusses how his career journey has epitomized the ability to solve problems, which is essentially the role of drug development. It has also led to the formation and strategic approach to his company’s early-stage clinical trials for using the microbiome to address chronic inflammatory diseases.Published on: March 7, 2023https://soundcloud.com/act-magazine/treat-disease-not-the-symptoms...

Read More

SFA Therapeutics will begin testing of SFA001 in a Phase 1 exploratory trial at Einstein Hospital in Philadelphia 1Q 2023 Dr Manisha Verma MD, MPH to act as principal investigator SFA Therapeutics to test its novel anti-inflamaatory compound, SFA001 in NASH patients. SFA001 is a powerful microbiome derived orally active small molecule has been shown to greatly reduce chronic inflammation. Chronic inflammation leads to the activation of...

Read More

Tales From the 2022 Biotech VC Fundraising Trail After the bonanza of 2021, life-sciences entrepreneurs reset their expectations as financing contracted SFA Therapeutics CEO & Co-Founder, Ira Spector, PhD discusses Startup Biotech funding in The Wall Street Journal Wall Street Journal article titled   'Biotech Startup Fundraising Fell in 2022.'by Brian Gormley in the December 23, 2022, print edition. ...

Read More

BIOTECH SHOWCASE: THE INVESTOR CONFERENCE FOR INNOVATORS Ira Spector, CEO of SFA Therapeutics will be presenting a corporate update at the Biotech Showcase,on January 11, 2023, at 10:45 AM in the Franciscan Ballroom A, at the Hilton Hotel in Union Square in San Francisco. Biotech Showcase™ and its family of events, China Showcase, Digital Medicine & Medtech Showcase and Seed Showcase, are investor conferences devoted to providing...

Read More

SFA Therapeutics was accepted into the highly competitive summer Y-Combinator Summer Cohort. Y-Combinator  is an American seed money startup accelerator launched in March 2005. It has been used to launch more than 2,000 companies, including Stripe, Airbnb, Cruise, PagerDuty, DoorDash, Coinbase, Instacart, Dropbox, Twitch, and Reddit   These Philly startups were accepted into Y Combinator’s summer 2021 cohort...

Read More

JENKINTOWN, PA, UNITED STATES, April 8, 2021 /EINPresswire.com/ — SFA Therapeutics, Inc., a clinical-stage biotechnology company, is pleased to announced the start of our first clinical trial for the treatment of “the appearance of the structure of skin with plaques due to psoriasis.” SFA plans to expand the evaluation of one of its six microbiome-derived drugs, SFA002, in this new trial. This 30-subject open-label clinical trial in...

Read More

Investors Meet Thirty of Top Startups in America-Angel Venture TUE, OCT 13 2020 9:00 AM—FRI, OCT 30 2020 4:00 PM SFA Therapeutics has been selected to present at the The 24th annual Angel Venture Fair It is virtual this year . There were over 150 applicants and our 85 judges narrowed down to this amazing cross section of companies.  What is unique about this program is that entrepreneurs will present live twice for 10...

Read More